| Citation: | WANG Linping, SHI Yongcun, ZHANG Hengfang, LI Na, LI Lijuan. Correlation between serum hs-CRP, five thyroid function parameters, and the severity of depression[J]. Chinese Journal of General Practice, 2026, 24(4): 630-632. doi: 10.16766/j.cnki.issn.1674-4152.004456 |
| [1] |
吴国平, 魏景明, 黄悦勤, 等. 精神分裂症、抑郁症和双相障碍住院患者的疾病成本[J]. 中国心理卫生杂志, 2024, 38(1): 9-15.
|
| [2] |
徐睿. 抑郁症的发病机制和中西医治疗进展[J]. 中华中医药杂志, 2021, 36(9): 5436-5440.
XU R. Pathogenesis of depression and the treatment progress from traditional Chinese and Western medicine[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2021, 36(9): 5436-5440.
|
| [3] |
CUI L, LI S, WANG S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment[J]. Signal Transduct Target Ther, 2024, 9(1): 30. DOI: 10.1038/s41392-024-01738-y.
|
| [4] |
曹悦, 崔健, 肖心怡, 等. 抑郁症神经认知功能障碍的研究进展及其心理评估[J]. 神经疾病与精神卫生, 2023, 23(4): 264-269.
CAO Y, CUI J, et al. Research progress on neurocognitive dysfunction in depression and its psychological assessment[J]. Journal of Neuroscience and Mental Health, 2023, 23(4): 264-269.
|
| [5] |
米文芳, 董强利, 张兰. 青少年抑郁症认知功能损害及影响因素的研究进展[J]. 新医学, 2023, 54(1): 13-16.
MI W F, DONG Q L, ZHANG L. Research progress on cognitive impairment and influencing factors in adolescents with depression[J]. Journal of New Medicine, 2023, 54(1): 13-16.
|
| [6] |
CLESSE C, YAQOOB M M, JAYAKUMAR S, et al. Investigating inflammation in depression in the chronically ill: theoretical model and perspectives[J]. J R Coll Physicians Edinb, 2022, 52(3): 247-252. doi: 10.1177/14782715221115776
|
| [7] |
袁正玮, 马莉莉, 孟小靖, 等. 抑郁症患者甲状腺素水平紊乱与生物节律之间的关系[J]. 安徽医学, 2023, 44(5): 497-500.
YUAN Z W, MA L L, et al. Relationship between disturbed thyroxin levels and biorhythms in patients with depression[J]. Anhui Medical Journal, 2023, 44(5): 497-500.
|
| [8] |
周勤, 乔娟, 王威, 等. 血清hs-CRP水平与青少年首发抑郁症的相关性研究[J]. 现代医学, 2022, 50(1): 105-110.
ZHOU Q, QIAO J, et al. Correlation study of serum hs-CRP and the first-episode depression in adolescents[J]. Modern Medicine, 2022, 50(1): 105-110.
|
| [9] |
ROA DUEÑAS O H, HOFMAN A, LUIK A I, et al. The cross-sectional and longitudinal association between thyroid function and depression: a population-based study[J]. J Clin Endocrinol Metab, 2024, 109(5): e1389-e1399. doi: 10.1210/clinem/dgad620
|
| [10] |
中华医学会精神病学分会. 中国精神障碍分类与诊断标准第三版(精神障碍分类)[J]. 中华精神科杂志, 2001, 34(3): 184-188.
Chinese Society of Psychiatry. Chinese Classification of Mental Disorders, 3rd ed. (Classification of Mental Disorders)[J]. Chinese Journal of Psychiatry, 2001, 34(3): 184-188.
|
| [11] |
FAVA G A, KELLNER R, MUNARI F, et al. The Hamilton Depression Rating Scale in normals and depressives[J]. Acta Psychiatr Scand, 1982, 66(1): 26-32. doi: 10.1111/j.1600-0447.1982.tb00911.x
|
| [12] |
王媛媛, 甘建光, 陈晶, 等. 失效模式与效应分析风险管理在住院抑郁症患者自杀预防中的应用[J]. 中华全科医学, 2024, 22(4): 633-637.
WANG Y Y, GAN J G, et al. The application of failure mode and effect analysis in risk management for suicide prevention in hospitalized patients with depression[J]. Chinese Journal of General Practice, 2024, 22(4): 633-637.
|
| [13] |
SIPAHI H, MAT A F, OZHAN Y, et al. The interrelation between oxidative stress, depression and inflammation through the kynurenine pathway[J]. Curr Top Med Chem, 2023, 23(6): 415-425. doi: 10.2174/1568026623666221223111309
|
| [14] |
孙婷, 乐娟, 李艳. 绝经期女性抑郁症患者血清雌二醇和超敏C反应蛋白水平变化及临床意义[J]. 微循环学杂志, 2021, 31(4): 27-31.
SUN T, LE J, LI Y. Changes and Clinical Significance of Serum Estradiol and High-sensitivity C-reactive Protein in Menopausal Women of Depression[J]. Chinese Journal of Microcirculation, 2021, 31(4): 27-31.
|
| [15] |
李鑫, 孙妍, 陈薇, 等. 甲状腺激素、性激素、皮质醇水平对评估首发女性抑郁障碍严重程度的临床意义[J]. 中华全科医学, 2024, 22(5): 828-832.
LI X, SUN Y, et al. Clinical significance of thyroid hormones, sex hormones, and cortisol levels in assessing the severity of first-episode female depression disorder[J]. Chinese Journal of General Practice, 2024, 22(5): 828-832.
|
| [16] |
覃贝芬, 陆喜建, 姚家伟, 等. 伴与不伴有精神病性症状的青少年抑郁症患者甲状腺激素水平比较[J]. 临床精神医学杂志, 2022, 32(3): 224-226.
QIN B F, LU X J, et al. Comparison of thyroid hormone levels in depressive adolescent patients with or without psychotic symptoms[J]. Journal of Clinical Psychiatry, 2022, 32(3): 224-226.
|
| [17] |
王明慧, 董楠. 抑郁症患者血清同型半胱氨酸水平与抑郁症状和认知水平的相关性研究[J]. 微循环学杂志, 2023, 33(4): 80-83.
WANG M H, DONG N. NOT_FOUND[J]. Chinese Journal of Microcirculation, 2023, 33(4): 80-83.
|
| [18] |
庄二阳, 乔娟, 赵后锋, 等. 血清超敏C反应蛋白与伴躯体症状抑郁症的临床相关性研究[J]. 精神医学杂志, 2021, 34(2): 140-144.
ZHUANG E Y, QIAO J, et al. Clinical correlation between serum hypersensitive C-reactive protein and depression with somatic symptoms[J]. Journal of Psychiatry, 2021, 34(2): 140-144.
|
| [19] |
李睿博, 杨靖, 石元洪. 血清补体C1q、甲状腺激素与抑郁症发病的相关性研究[J]. 中华行为医学与脑科学杂志, 2020, 29(6): 529-534.
LI R B, YANG J, SHI Y H. Correlation between serum complement C1q, thyroid hormone and depression[J]. Chin J Behav Med Brain Sci, 2020, 29(6): 529-534.
|
| [20] |
翟华丽, 赵芝荣, 韩双, 等. 抑郁症患者甲状腺激素和25-羟维生素D3水平及其临床意义[J]. 广西医学, 2020, 42(16): 2066-2068, 2075.
ZHAI H L, ZHAO Z R, et al. NOT_FOUND[J]. Guangxi Medical Journal, 2020, 42(16): 2066-2068, 2075.
|
| [21] |
王娜, 傅希玥, 张帆, 等. 甲状腺激素及脑源性神经营养因子前体水平与抑郁症的关系研究[J]. 中国全科医学, 2020, 23(9): 1100-1104.
WANG N, FU X Y, et al. Relationships of Thyroid Hormone and proBDNF with Depression[J]. Chinese General Practice, 2020, 23(9): 1100-1104.
|